Evonik Corporation

A global leader for biomaterials with a broad portfolio of products, technologies, and services, Evonik has served as a development and solutions provider to many of the world’s largest and most innovative medical device companies for over 30 years. Our portfolio includes a range of bioresorbable polymers, surface modification technologies, nature-identical biomaterials including a non-animal derived recombinant collagen platform and bacterial nano-cellulose, and CDMO services for custom polymer synthesis, and the development of medical device parts to match specific application requirements.